RNA therapy for polyglutamine neurodegenerative diseases.
about
Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration.SMMRNA: a database of small molecule modulators of RNA.Targeted Molecular Therapies for SBMA.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.An understanding of spinocerebellar ataxia.Transfer of genetic therapy across human populations: molecular targets for increasing patient coverage in repeat expansion diseases.Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.
P2860
Q37539531-28EB9614-01BB-43BA-AEA9-5317B207D73CQ38108756-1D2B01D9-F4C6-40C4-A48B-97938BF45275Q38491740-DB0DA9CD-772A-4680-953A-E6575EDCE4E7Q38635851-24340223-B063-4A39-8922-289EFD8F9C8DQ39112084-8E910B5F-56AA-4677-89D1-8D7DE58007B2Q40211902-373815C2-7BD9-4CF3-9DA6-B75C720ABEF3Q43082851-49276F64-6C01-42A1-9C90-5A86DDEA8AA1Q45735441-5677CDCA-ED5C-49DE-B68E-034C5CFA57CD
P2860
RNA therapy for polyglutamine neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
RNA therapy for polyglutamine neurodegenerative diseases.
@en
RNA therapy for polyglutamine neurodegenerative diseases.
@nl
type
label
RNA therapy for polyglutamine neurodegenerative diseases.
@en
RNA therapy for polyglutamine neurodegenerative diseases.
@nl
prefLabel
RNA therapy for polyglutamine neurodegenerative diseases.
@en
RNA therapy for polyglutamine neurodegenerative diseases.
@nl
P2860
P356
P1476
RNA therapy for polyglutamine neurodegenerative diseases
@en
P2093
Lauren M Watson
P2860
P356
10.1017/ERM.2011.1
P577
2012-01-31T00:00:00Z